PASG compared with TCRX: revenue, margins and what each company keeps, and the suppliers and customers both name

PASGPassage BIO, Inc.

Mkt capRevenueRevenue

TCRXTScan Therapeutics, Inc.

Mkt capRevenueRevenue

Compare

PASGPassage BIO, Inc.

TCRXTScan Therapeutics, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

Supply-chain overlap

Revenue flow

PASG: latest quarter is a loss; flow not drawable. TCRX: latest quarter is a loss; flow not drawable.Method ›

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only PASG 1

—Gemmaunlistedsupplier

Shared 0

No shared counterparties.

Only TCRX 4

AMGNAmgencustomer

NVSNovartiscustomer

—Brigham and Women's Hospital, Inc. (BWH)unlistedsupplier

—Phsa

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

unlistedsupplier

PASGPassage BIO, Inc.

3.44▼−2.27%

Mkt cap$11.1MRevenue$99,000Q3 FY24Revenue—

TCRXTScan Therapeutics, Inc.

0.18▲+4.13%

Regular sessionSep 2 '83

Mkt cap$11.8MRevenue$1MQ2 FY26Revenue$10MFY25

Compare

Regular sessionSep 2 '83

PASGPassage BIO, Inc.

TCRXTScan Therapeutics, Inc.

3.44▼−2.27%

Price

0.18▲+4.13%

$11.1M

Mkt cap

$11.8M

Q3 FY24$99,000

Revenue

$1MQ2 FY26

—

Revenue

$10MFY25

PASG3.44▼−2.27%vsTCRX0.18▲+4.13%Regular sessionSep 2 '83

Price

rebased to 0%

PASG, solidTCRX, dashed